Vivity Outcomes in Patients With Early Stage Glaucoma

Completed

Conditions studied: Glaucoma, Cataract, Presbyopia

In brief

The goal of the study is to determine the visual outcomes in patients with mild, pre-perimetric glaucoma who undergo cataract surgery with implantation of the Alcon Vivity Extended Range Intraocular Lens (IOL).

Key facts

Study ID

NCT04670575

Run by

Vance Thompson Vision

People needed

27

Starts

2021-01-01

Expected to finish

2022-11-30

Last updated by the study team

2024-05-20

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients at least age 45 years of age undergoing uncomplicated cataract surgery with optional concomitant minimally invasive glaucoma surgery (MIGS)
• Subjects with documented diagnosis of pre-perimetric glaucoma
• Calculated lens power within Vivity/Vivity toric range
• Willing and able to comprehend informed consent and complete 4-6 month post-op visit
• Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion

You may not qualify if…

• Ocular comorbidity, other than pre-perimetric glaucoma, that could reduce the potential postoperative BCDVA
• Previous ocular surgery including refractive surgery
• Subjects who are pregnant or plan to become pregnant during the course of the study.

Where it is running

• Vance Thompson Vision — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.